ABVC BioPharma, Inc.
ABVC
$2.73
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -139.52% | 70.29% | 159.82% | 94.38% | 58.37% |
| Total Depreciation and Amortization | -29.31% | 11.12% | -50.11% | -6.67% | 1,532.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 272.77% | -90.18% | -1,064.21% | -82.62% | 5.64% |
| Change in Net Operating Assets | -309.81% | 94.30% | 53.78% | 600.00% | -81.41% |
| Cash from Operations | -322.99% | 43.52% | -14.66% | 112.64% | 76.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.74% | -- | -- | -- | -13.84% |
| Cash from Investing | -32.74% | -- | -- | -- | -13.84% |
| Total Debt Issued | -98.99% | -- | 526.34% | 100.00% | 2,913.61% |
| Total Debt Repaid | -- | -- | 5.09% | -- | -- |
| Issuance of Common Stock | 1,456.34% | -- | -- | -96.79% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.76% | -92.44% | -100.00% | -100.00% | -- |
| Cash from Financing | 140.25% | -53.60% | 1,414.32% | -108.78% | 2,638.61% |
| Foreign Exchange rate Adjustments | -837.04% | 126.05% | 103.67% | -99.48% | -101.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 278.04% | -80.28% | 123.23% | -92.84% | 107.98% |